Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Hemorrhage | 2 | 2019 | 81 | 1.120 |
Why?
|
| Tonsillectomy | 2 | 2019 | 109 | 1.020 |
Why?
|
| Cleft Lip | 2 | 2024 | 133 | 0.860 |
Why?
|
| Cleft Palate | 2 | 2024 | 153 | 0.850 |
Why?
|
| Vagus Nerve Stimulation | 4 | 2022 | 57 | 0.660 |
Why?
|
| Leadership | 1 | 2022 | 246 | 0.640 |
Why?
|
| Ear Canal | 1 | 2015 | 10 | 0.470 |
Why?
|
| Ear Diseases | 1 | 2015 | 21 | 0.470 |
Why?
|
| Otologic Surgical Procedures | 1 | 2015 | 25 | 0.470 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2015 | 12 | 0.460 |
Why?
|
| Otitis Media with Effusion | 2 | 2024 | 25 | 0.460 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2015 | 37 | 0.460 |
Why?
|
| Sildenafil Citrate | 1 | 2015 | 57 | 0.460 |
Why?
|
| Middle Ear Ventilation | 2 | 2024 | 35 | 0.460 |
Why?
|
| Lymphatic Abnormalities | 1 | 2015 | 36 | 0.450 |
Why?
|
| Internship and Residency | 2 | 2022 | 1252 | 0.440 |
Why?
|
| Vocal Cord Paralysis | 1 | 2015 | 69 | 0.430 |
Why?
|
| Reoperation | 2 | 2019 | 853 | 0.390 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 316 | 0.380 |
Why?
|
| Pneumonia, Aspiration | 1 | 2011 | 18 | 0.350 |
Why?
|
| Turbinates | 1 | 2010 | 12 | 0.340 |
Why?
|
| Nasal Obstruction | 1 | 2010 | 15 | 0.330 |
Why?
|
| Larynx | 1 | 2011 | 75 | 0.330 |
Why?
|
| Electrodes, Implanted | 1 | 2011 | 175 | 0.320 |
Why?
|
| Rhinoplasty | 1 | 2010 | 46 | 0.310 |
Why?
|
| Trachea | 1 | 2011 | 210 | 0.310 |
Why?
|
| Macroglossia | 1 | 2008 | 2 | 0.300 |
Why?
|
| Glossectomy | 1 | 2008 | 9 | 0.300 |
Why?
|
| Device Removal | 1 | 2011 | 225 | 0.300 |
Why?
|
| Tongue | 1 | 2008 | 29 | 0.300 |
Why?
|
| Lactic Acid | 1 | 2006 | 159 | 0.230 |
Why?
|
| Polymers | 1 | 2006 | 110 | 0.230 |
Why?
|
| Audiology | 1 | 2024 | 6 | 0.220 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 5405 | 0.220 |
Why?
|
| Humans | 24 | 2024 | 132336 | 0.210 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 271 | 0.200 |
Why?
|
| Child | 9 | 2019 | 25823 | 0.190 |
Why?
|
| Otolaryngology | 1 | 2024 | 108 | 0.190 |
Why?
|
| Stroke Rehabilitation | 1 | 2022 | 70 | 0.190 |
Why?
|
| Retrospective Studies | 7 | 2019 | 17363 | 0.180 |
Why?
|
| Trust | 1 | 2022 | 81 | 0.180 |
Why?
|
| Surgery, Plastic | 1 | 2022 | 103 | 0.170 |
Why?
|
| Lymphangioma, Cystic | 2 | 2010 | 18 | 0.170 |
Why?
|
| Male | 13 | 2019 | 65054 | 0.160 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 564 | 0.160 |
Why?
|
| Female | 13 | 2019 | 70788 | 0.160 |
Why?
|
| Treatment Outcome | 7 | 2022 | 13016 | 0.140 |
Why?
|
| Adolescent | 7 | 2019 | 20552 | 0.130 |
Why?
|
| Epilepsy | 2 | 2022 | 891 | 0.120 |
Why?
|
| Suture Techniques | 1 | 2017 | 186 | 0.120 |
Why?
|
| Odontogenic Tumors | 1 | 2015 | 1 | 0.120 |
Why?
|
| Hearing Tests | 1 | 2015 | 16 | 0.120 |
Why?
|
| Myxoma | 1 | 2015 | 29 | 0.120 |
Why?
|
| Hearing | 1 | 2015 | 61 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2013 | 128 | 0.120 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2014 | 7 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 150 | 0.110 |
Why?
|
| Mouth Abnormalities | 1 | 2014 | 15 | 0.110 |
Why?
|
| Syndactyly | 1 | 2014 | 24 | 0.110 |
Why?
|
| Apnea | 1 | 2014 | 31 | 0.110 |
Why?
|
| Maxilla | 1 | 2014 | 39 | 0.110 |
Why?
|
| Chromosome Duplication | 1 | 2015 | 149 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 2 | 2010 | 615 | 0.110 |
Why?
|
| Fingers | 1 | 2014 | 67 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 235 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2021 | 1071 | 0.110 |
Why?
|
| Head | 1 | 2015 | 115 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 1068 | 0.110 |
Why?
|
| Mandible | 1 | 2014 | 82 | 0.110 |
Why?
|
| Neck | 1 | 2015 | 142 | 0.110 |
Why?
|
| Eye Abnormalities | 1 | 2014 | 104 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2015 | 14853 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 21 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2019 | 3139 | 0.100 |
Why?
|
| Hemangioma, Capillary | 1 | 2013 | 17 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 747 | 0.100 |
Why?
|
| Knee Joint | 1 | 2014 | 172 | 0.100 |
Why?
|
| Hemangiosarcoma | 1 | 2013 | 46 | 0.100 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2013 | 74 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 167 | 0.100 |
Why?
|
| Sirolimus | 1 | 2013 | 241 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1297 | 0.090 |
Why?
|
| Propranolol | 1 | 2011 | 110 | 0.090 |
Why?
|
| Rhinomanometry | 1 | 2010 | 2 | 0.090 |
Why?
|
| Laryngeal Neoplasms | 1 | 2011 | 91 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2011 | 133 | 0.080 |
Why?
|
| Hemangioma | 1 | 2011 | 97 | 0.080 |
Why?
|
| Hypertrophy | 1 | 2010 | 101 | 0.080 |
Why?
|
| Syncope | 1 | 2010 | 51 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 207 | 0.080 |
Why?
|
| Laryngismus | 1 | 2009 | 4 | 0.080 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2009 | 39 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 608 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 983 | 0.070 |
Why?
|
| Botulinum Toxins | 1 | 2009 | 122 | 0.070 |
Why?
|
| Catheter Ablation | 1 | 2010 | 241 | 0.070 |
Why?
|
| Movement | 1 | 2008 | 168 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1458 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 410 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3853 | 0.060 |
Why?
|
| Absorbable Implants | 1 | 2006 | 26 | 0.060 |
Why?
|
| Polyesters | 1 | 2006 | 41 | 0.060 |
Why?
|
| Seizures | 1 | 2011 | 895 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 2006 | 116 | 0.060 |
Why?
|
| Infant | 3 | 2015 | 13192 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 175 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2015 | 6540 | 0.050 |
Why?
|
| Vagus Nerve | 1 | 2022 | 46 | 0.050 |
Why?
|
| Hospitalization | 1 | 2011 | 1894 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 479 | 0.050 |
Why?
|
| Career Choice | 1 | 2022 | 161 | 0.040 |
Why?
|
| Prognosis | 1 | 2011 | 5009 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2013 | 4725 | 0.040 |
Why?
|
| Young Adult | 1 | 2015 | 9945 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 569 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2022 | 206 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2010 | 3710 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 288 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2022 | 607 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2303 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2015 | 10 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2015 | 16 | 0.030 |
Why?
|
| Chromogranins | 1 | 2015 | 28 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2013 | 30 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2013 | 140 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2013 | 168 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 202 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 757 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 1047 | 0.020 |
Why?
|
| Biopsy | 1 | 2015 | 1288 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 447 | 0.020 |
Why?
|
| Sclerosing Solutions | 1 | 2010 | 12 | 0.020 |
Why?
|
| Lymphangiogenesis | 1 | 2010 | 17 | 0.020 |
Why?
|
| Lymphatic Vessels | 1 | 2010 | 36 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 998 | 0.020 |
Why?
|
| Sclerotherapy | 1 | 2010 | 39 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 634 | 0.020 |
Why?
|
| Bleomycin | 1 | 2010 | 114 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 704 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 701 | 0.020 |
Why?
|
| Vascular Malformations | 1 | 2010 | 111 | 0.020 |
Why?
|
| Polysomnography | 1 | 2009 | 152 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 471 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2169 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1683 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 1367 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3697 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 4545 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2010 | 906 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 3358 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 1720 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7567 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2014 | 8566 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 6248 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 10910 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 34989 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6455 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 18571 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 21379 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 31618 | 0.010 |
Why?
|